Comparison of the elution characteristics of individual forms of lovastatin in both isocratic and gradient modes and HPLC-PDA method development for pure and fermentation-derived lovastatin. 2017

Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
a Department of Biotechnology , National Institute of Technology Raipur , Raipur , Chhattisgarh , India.

The elution characteristics of lovastatin were studied by varying the composition of mobile phase in both isocratic and gradient elution modes to comprehend the role of organic modifier and acidifier on the overall analysis time and retention time of individual forms of lovastatin. Acetonitrile has influenced on the overall analysis time, whereas the acidifier determines the retention time of hydroxy acid form of lovastatin and the retention time gap between the individual forms. A combination of acetonitrile and 0.1% trifluoroacetic acid (TFA) (60:40, v/v) in isocratic elution mode eluted both hydroxy acid and lactone forms of lovastatin at 4.5 and 5.4 min, respectively. This appears to be a better approach for the separation of pharmaceutical and clinical lovastatin samples. At isocratic elution mode, a mixture of acetonitrile and either 0.05% TFA or 0.1% H3PO4 of 60:40 (v/v) has eluted both hydroxy acid and lactone forms of lovastatin at 10 ± 0.5 and 17 ± 0.5 min, respectively. This is suitable for the fermentation-derived samples or for the complex mixtures of structural analogs. The fermentation broth (pH not adjusted) extracted with ethyl acetate at a ratio of 1:1 (v/v) at 60°C for 30 min was the optimal extraction condition for lovastatin.

UI MeSH Term Description Entries
D007218 Industrial Microbiology The study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms. Microbiology, Industrial
D008148 Lovastatin A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. Lovastatin, 1 alpha-Isomer,Mevinolin,6-Methylcompactin,Lovastatin, (1 alpha(S*))-Isomer,MK-803,Mevacor,Monacolin K,1 alpha-Isomer Lovastatin,6 Methylcompactin,Lovastatin, 1 alpha Isomer,MK 803,MK803,alpha-Isomer Lovastatin, 1
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D032741 Monascus A genus in the family Monascaceae, order EUROTIALES. One species, Monascus purpureus, has multiple uses in traditional Chinese medicine (MEDICINE, CHINESE TRADITIONAL). Monascus albidus,Monascus anka,Monascus araneosus,Monascus rubiginosus,Monascus purpureus

Related Publications

Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
March 2010, Journal of mass spectrometry : JMS,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
October 2018, Journal of chromatography. A,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
November 2019, Die Pharmazie,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
January 2007, Journal of pharmaceutical and biomedical analysis,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
January 2022, Journal of pharmaceutical and biomedical analysis,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
July 2006, Journal of chromatography. A,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
January 2018, Journal of analytical methods in chemistry,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
March 2006, Journal of chromatography. A,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
March 2009, Journal of chromatography. A,
Ayothiraman Seenivasan, and Sathyanarayana N Gummadi, and Tapobrata Panda
January 2009, Journal of separation science,
Copied contents to your clipboard!